Prognostic Value of Serum Cholinesterase Levels for In-Hospital Mortality among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

References

• Vestbo J. COPD: definition and phenotypes. Clin Chest Med. 2014;35(1):1–6. DOI:10.1016/j.ccm.2013.10.010
   PubMed Web of Science ®Google Scholar
• López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. DOI:10.1111/resp.12660
   PubMed Web of Science ®Google Scholar
• Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations. Clin Chest Med. 2020;41(3):421–438. DOI:10.1016/j.ccm.2020.06.007
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Birk R, Brealey N, et al. Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses. ERJ Open Res. 2018;4(2):00119–2017. DOI:10.1183/23120541.00119-2017
   PubMedGoogle Scholar
• Donaldson GC, Law M, Kowlessar B, et al. Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(8):943–950. DOI:10.1164/rccm.201412-2269OC
   PubMed Web of Science ®Google Scholar
• Vermeersch K, Gabrovska M, Aumann J, et al. Azithromycin during acute chronic obstructive pulmonary disease exacerbations requiring hospitalization (BACE). a multicenter, randomized, Double-Blind, placebo-controlled trial. Am J Respir Crit Care Med. 2019;200(7):857–868. DOI:10.1164/rccm.201901-0094OC
   PubMed Web of Science ®Google Scholar
• Mathioudakis AG, Janssens W, Sivapalan P, et al. Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits. Thorax. 2020;75(6):520–527. DOI:10.1136/thoraxjnl-2019-214484
   PubMed Web of Science ®Google Scholar
• Holmstedt B. Distribution and determination of cholinesterases in mammals. Bull World Health Org. 1971;44(1–3):99–107.
   PubMed Web of Science ®Google Scholar
• Zivkovic AR, Bender J, Brenner T, et al. Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response. J Inflamm Res. 2016;9:221–230. DOI:10.2147/JIR.S117590
   PubMed Web of Science ®Google Scholar
• Cacciatore F, Della-Morte D, Basile C, et al. Butyryl-cholinesterase is related to muscle mass and strength. A new biomarker to identify elderly subjects at risk of sarcopenia. Biomark Med. 2015;9(7):669–678. DOI:10.2217/bmm.15.28
   PubMed Web of Science ®Google Scholar
• Santarpia L, Grandone I, Contaldo F, et al. Butyrylcholinesterase as a prognostic marker: a review of the literature. J Cachexia Sarcopenia Muscle. 2013;4(1):31–39. DOI:10.1007/s13539-012-0083-5
   PubMed Web of Science ®Google Scholar
• Bukowska B, Sicińska P, Pająk A, et al. Oxidative stress and damage to erythrocytes in patients with chronic obstructive pulmonary disease–changes in ATPase and acetylcholinesterase activity. Biochem Cell Biol. 2015;93(6):574–580. DOI:10.1139/bcb-2015-0066
   PubMedGoogle Scholar
• Ben Anes A, Ben Nasr H, Garrouch A, et al. Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers. Mol Cell Biochem. 2018;445(1–2):1–11. DOI:10.1007/s11010-017-3246-z
   PubMed Web of Science ®Google Scholar
• Koie T, Ohyama C, Yamamoto H, et al. Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy. Urol Oncol. 2014;32(6):820–825. DOI:10.1016/j.urolonc.2014.03.010
   PubMed Web of Science ®Google Scholar
• Takano Y, Haruki K, Tsukihara S, et al. The impact of low serum cholinesterase levels on survival in patients with colorectal cancer. Int J Colorectal Dis. 2022;37(4):869–877. DOI:10.1007/s00384-022-04119-5
   PubMed Web of Science ®Google Scholar
• Seo M, Yamada T, Tamaki S, et al. Prognostic significance of serum cholinesterase in patients with acute decompensated heart failure: a prospective comparative study with other nutritional indices. Am J Clin Nutr. 2019;110(2):330–339. DOI:10.1093/ajcn/nqz103
   PubMed Web of Science ®Google Scholar
• Michels B, Holzamer A, Graf BM, et al. Butyrylcholinesterase as a perioperative complication marker in patients after transcatheter aortic valve implantation: a prospective observational study. BMJ Open. 2021;11(7):e042857. DOI:10.1136/bmjopen-2020-042857
   PubMed Web of Science ®Google Scholar
• Adam EH, Haas V, Lindau S, et al. Cholinesterase alterations in delirium after cardiosurgery: a german monocentric prospective study. BMJ Open. 2020;10(1):e031212. DOI:10.1136/bmjopen-2019-031212
   PubMed Web of Science ®Google Scholar
• Takano Y, Haruki K, Tsukihara S, et al. Preoperative serum cholinesterase levels as a risk factor of postoperative complications for the elderly undergoing emergency surgery. Surg Today. 2021;51(11):1828–1834. DOI:10.1007/s00595-021-02288-4
   PubMed Web of Science ®Google Scholar
• Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease. Ann Intern Med. 2020;173(3):Itc17–itc32. DOI:10.7326/AITC202008040
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. DOI:10.1183/09031936.00080312
   PubMed Web of Science ®Google Scholar
• Hu G, Wu Y, Zhou Y, et al. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2729–2736. DOI:10.2147/COPD.S112882
   PubMed Web of Science ®Google Scholar
• Shorr AF, Sun X, Johannes RS, et al. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011;140(5):1177–1183. DOI:10.1378/chest.10-3035
   PubMed Web of Science ®Google Scholar
• Koç Ç, Şahin F. What are the most effective factors in determining future exacerbations, morbidity weight, and mortality in patients with COPD attack? Medicina (Kaunas, Lithuania). 2022;58(2):163. DOI:10.3390/medicina58020163
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Manco A, Guerrero M, et al. Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD. Intern Emerg Med. 2021;16(2):401–408. DOI:10.1007/s11739-020-02420-1
   PubMed Web of Science ®Google Scholar
• Oster HS, Dolev Y, Kehat O, et al. Serum hypoalbuminemia is a long-term prognostic marker in medical hospitalized patients, irrespective of the underlying disease. JCM. 2022;11(5):1207. DOI:10.3390/jcm11051207
   Google Scholar
• Pellicori P, McConnachie A, Carlin C, et al. Predicting mortality after hospitalisation for COPD using electronic health records. Pharmacol Res. 2022;179:106199. DOI:10.1016/j.phrs.2022.106199
   PubMed Web of Science ®Google Scholar
• García-Sanz MT, Cánive-Gómez JC, Senín-Rial L, et al. One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease. J Thorac Dis. 2017;9(3):636–645. DOI:10.21037/jtd.2017.03.34
   PubMed Web of Science ®Google Scholar
• Charlson ME, Carrozzino D, Guidi J, et al. Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91(1):8–35. DOI:10.1159/000521288
   PubMed Web of Science ®Google Scholar
• Ho TW, Tsai YJ, Ruan SY, et al. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study. PLoS One. 2014;9(12):e114866. DOI:10.1371/journal.pone.0114866
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. DOI:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Celli B, Locantore N, Yates JC, et al. Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort. Eur Respir J. 2021;57(3):2001339. DOI:10.1183/13993003.01339-2020
   PubMed Web of Science ®Google Scholar
• Gómez-Rosero JA, Cáceres-Galvis C, Ascuntar J, et al. Biomarkers as a prognostic factor in COPD exacerbation: a cohort study. COPD. 2021;18(3):325–332. DOI:10.1080/15412555.2021.1922370
   PubMedGoogle Scholar
• Leuzzi G, Galeone C, Taverna F, et al. C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis. Eur Respir Rev. 2017;26(143):160070. DOI:10.1183/16000617.0070-2016
   PubMed Web of Science ®Google Scholar
• Lomholt FK, Laulund AS, Bjarnason NH, et al. Meta-analysis of routine blood tests as predictors of mortality in COPD. Eur Clin Respir J. 2014;1(1):24110. DOI:10.3402/ecrj.v1.24110
   PubMedGoogle Scholar
• Seo M, Yamada T, Tamaki S, et al. Prognostic significance of serum cholinesterase level in patients with acute decompensated heart failure with preserved ejection fraction: insights from the PURSUIT-HFpEF registry. J Am Heart Assoc. 2020;9(1):e014100.
   PubMed Web of Science ®Google Scholar
• Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454–475. DOI:10.1183/09059180.00008612
   PubMedGoogle Scholar
• Dávalos-Yerovi V, Marco E, Sánchez-Rodríguez D, et al. Malnutrition according to GLIM criteria is associated with mortality and hospitalizations in rehabilitation patients with stable chronic obstructive pulmonary disease. Nutrients. 2021;13(2):369. DOI:10.3390/nu13020369
   PubMed Web of Science ®Google Scholar
• Persson HL, Sioutas A, Kentson M, et al. Skeletal myosteatosis is associated with systemic inflammation and a loss of muscle bioenergetics in stable COPD. J Inflamm Res. 2022;15:4367–4384. DOI:10.2147/JIR.S366204
   PubMed Web of Science ®Google Scholar
• Kaluźniak-Szymanowska A, Krzymińska-Siemaszko R, Deskur-Śmielecka E, et al. Malnutrition, sarcopenia, and malnutrition-sarcopenia syndrome in older adults with COPD. Nutrients. 2021;14(1):44. DOI:10.3390/nu14010044
   PubMed Web of Science ®Google Scholar
• Miller J, Edwards LD, Agustí A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013;107(9):1376–1384. DOI:10.1016/j.rmed.2013.05.001
   PubMed Web of Science ®Google Scholar
• Pascual-González Y, López-Sánchez M, Dorca J, et al. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2018;13:3651–3662. DOI:10.2147/COPD.S178068
   PubMed Web of Science ®Google Scholar
• Jonsdottir B, Jaworowski A, San Miguel C, et al. IL-8 predicts early mortality in patients with acute hypercapnic respiratory failure treated with noninvasive positive pressure ventilation. BMC Pulm Med. 2017;17(1):35. DOI:10.1186/s12890-017-0377-7
   PubMedGoogle Scholar
• Echevarria C,Steer J,Heslop-Marshall K, et al. Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133–140. DOI:10.1136/thoraxjnl-2015-207775
   PubMed Web of Science ®Google Scholar